BMT
Phase NA Completed
10 enrolled
SICG
Phase NA Completed
36 enrolled 16 charts
BRUOG-407
Phase NA Completed
18 enrolled 8 charts
BMT CTN 1702
Phase NA Completed
1,753 enrolled
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Phase NA Completed
13 enrolled
Poly-CO
Phase NA Completed
60 enrolled
A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia
Phase NA Completed
30 enrolled
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
BioScoreSMP
Phase NA Completed
133 enrolled
MargheRITA
Phase NA Completed
124 enrolled
EVAADE
Phase NA Completed
15 enrolled
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
Phase NA Completed
10 enrolled 11 charts
The EMPATHY Pilot Study
Phase NA Completed
94 enrolled 13 charts
Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms
Phase NA Completed
102 enrolled
DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer
Phase NA Completed
25 enrolled
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
Phase NA Completed
47 enrolled
HCTDiet
Phase NA Completed
40 enrolled
Mini-allo
Phase NA Completed
36 enrolled
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Phase NA Completed
10 enrolled
CAR-LMC
Phase NA Completed
53 enrolled
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
Phase NA Completed
48 enrolled 7 charts
Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects
Phase NA Completed
38 enrolled
IM-TMI
Phase NA Completed
14 enrolled 14 charts
PLASMYC
Phase NA Completed
138 enrolled
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Phase NA Completed
18 enrolled 7 charts
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Phase NA Completed
8 enrolled 12 charts
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Phase NA Completed
39 enrolled 13 charts
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
Phase NA Completed
10 enrolled
TAR
Phase NA Completed
7 enrolled 8 charts
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
Phase NA Completed
876 enrolled
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Phase NA Completed
160 enrolled
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
Phase NA Completed
41 enrolled
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Phase NA Completed
29 enrolled
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
Phase NA Completed
17 enrolled
Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery
Phase NA Completed
39 enrolled
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
Phase NA Completed
62 enrolled 14 charts
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Phase NA Completed
68 enrolled
EvaTryMS
Phase NA Completed
250 enrolled
The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients
Phase NA Completed
128 enrolled
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
Phase NA Completed
26 enrolled 9 charts
EVITA-Pilot
Phase NA Completed
20 enrolled
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
Phase NA Completed
16 enrolled 9 charts
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
Phase NA Completed
80 enrolled
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
Phase NA Completed
48 enrolled 9 charts
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
Phase NA Completed
12 enrolled 10 charts
STIM 2
Phase NA Completed
220 enrolled
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
Phase NA Completed
40 enrolled
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
Phase NA Completed
68 enrolled
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Phase NA Completed
24 enrolled 11 charts
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases
Phase NA Completed
65 enrolled